Megestrol Acetate Suspension
Product Images NDC 51407-910

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 51407-910). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-910-24ol (Megestral Acetate 40 mg-mL)

51407-910-24ol (Megestral Acetate 40 mg-mL)
Label for Megestrol Acetate oral suspension, USP, 40 mg/mL strength. The label shows a 240 mL (8 fl. oz.) bottle size and includes storage and handling instructions. Marketed by GSMS, Incorporated, the label also contains a barcode, NDC 51407-910-24, and notes the product is a milky white, lemon-lime flavored oral suspension.*
FDA Label Image

Chemical Formula (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 01)

Chemical Formula (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 01)
Chemical structure diagram of megestrol acetate, USP. The structure displays its steroidal backbone with specific functional groups labeled, depicting the molecular arrangement of the active ingredient megestrol acetate.*
FDA Label Image

Trial 1 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 02)

Trial 1 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 02)
A line graph titled 'TRIAL 1' showing mean weight change in pounds over weeks for different dosage groups of Megestrol Acetate suspension (400 mg, 800 mg, 100 mg) and a placebo group. The x-axis represents time in weeks, and the y-axis represents weight change in pounds. Lines indicate weight increase or decrease for each dosage and placebo over the study period.*
FDA Label Image

Trial 2 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 03)

Trial 2 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 03)
A line graph titled 'TRIAL 2' showing mean weight change in pounds over 12 weeks. The x-axis represents weeks (0, 4, 8, 12) and the y-axis shows mean weight change from -3 to 12 pounds. Two lines compare weight change for 800 mg dosed and placebo groups, with data points at weeks 4, 8, and 12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.